|
× |
 |
Effects of Adjunctive Metformin on Metabolic Traits in Nondiabetic Clozapine-Treated Patients With Schizophrenia and the Effect of Metformin Discontinuation on Body Weight: A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
How the Probability and Potential Clinical Significance of Pharmacokinetically Mediated Drug-Drug Interactions Are Assessed in Drug Development: Desvenlafaxine as an Example PDF |
$40.00 |
|
$40.00 |
|
× |
|
Efficacy and Safety of Mirtazapine in Major Depressive Disorder Patients After SSRI Treatment Failure: An Open-Label Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Assessing the Efficacy of Desvenlafaxine for Improving Functioning and Well-Being Outcome Measures in Patients With Major Depressive Disorder: A Pooled Analysis of 9 Double-Blind, Placebo-Controlled, 8-Week Clinical Trials PDF |
$40.00 |
|
$40.00 |
|
× |
|
High False-Positive Rate of a Putative Biomarker Test to Aid in the Diagnosis of Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Prospective Observational Study of Obesity, Body Composition, and Insulin Resistance in 18 Women With Bipolar Disorder and 17 Matched Control Subjects PDF |
$40.00 |
|
$40.00 |
|
× |
|
Antipsychotic Drugs, Mood Stabilizers, and Risk of Pneumonia in Bipolar Disorder: A Nationwide Case-Control Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Etizolam Use Disorder and Withdrawal in a Patient in Sustained Remission From Opioid, Cocaine, and Methamphetamine Use Disorders PDF |
$40.00 |
|
$40.00 |
|
× |
|
Antipsychotic Treatment and the Occurrence of Venous Thromboembolism: A 10-Year Nationwide Registry Study PDF |
$40.00 |
|
$40.00 |
|
|
